Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product

Contraception
Eliana AmaralA Faúndes

Abstract

ACIDFORM is a microbicidal and contraceptive candidate with strong buffering capacity. This was a Phase I blinded, randomized and crossover clinical study on two products, ACIDFORM and a commercial nonoxynol-9 (N-9) product (2%), evaluating their vaginal safety in 20 couples aged between 19 and 45 years. The women had regular menses, underwent previous tubal ligation, were not breast-feeding, had no vaginal sign and symptom and were in a stable partnership; both partners had no previous STI. Colposcopy, vaginal microbiology, inflammation markers and subject complaints were studied after coitus. Women were randomly assigned sequentially to receive ACIDFORM 0-30 min (0-30 min before intercourse), ACIDFORM 8-10 h (8-10 h before intercourse) or N-9 0-30 min after a control cycle. Mild/moderate vulvar irritation was observed in five postcoital test colposcopies, burning and pruritus were reported in six treated cycles and non-irritation-related symptoms were found in five cycles with different treatments. No difference in vaginal pH, Nugent scores, H2O2-producing lactobacillus or leukocytes and interleukin 6 in the cervicovaginal lavage was found between the treatment and control cycles. ACIDFORM appears to be safe for clinical use ...Continue Reading

References

Aug 1, 1991·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·E NagyP A Mårdh
Dec 1, 1990·AIDS Research and Human Retroviruses·J OngradiM Bendinelli
Dec 1, 1985·British Journal of Obstetrics and Gynaecology·N F HannaI R McFadyen
Jun 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S L HillierD A Eschenbach
Feb 16, 1999·Journal of Medical Microbiology·R K PettitT A Hamer
Feb 15, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·J van De WijgertK Nelson
Feb 2, 2002·International Journal of Palliative Nursing·Susie Wilkinson

❮ Previous
Next ❯

Citations

Oct 18, 2006·BMC Infectious Diseases·A Robert NeurathYun-Yao Li
Nov 14, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ruth I Connor
Nov 1, 2006·Current Opinion in HIV and AIDS·Zeda F RosenbergMark Mitchnick
Mar 16, 2007·Expert Review of Medical Devices·Anita L Nelson
Jan 9, 2010·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·István Batár
Feb 18, 2010·Contraception·Claire E von MollendorfDoug Taylor
Nov 6, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Gavin P AndrewsDavid S Jones
Nov 11, 2008·The Lancet Infectious Diseases·Blayne Cutler, Jessica Justman
Mar 6, 2007·Lancet·Jan Balzarini, Lut Van Damme
Dec 17, 2008·BJOG : an International Journal of Obstetrics and Gynaecology·S Rowlands
Mar 18, 2011·Reviews in Medical Virology·Kevin K AriënGuido Vanham
Nov 14, 2006·Biologicals : Journal of the International Association of Biological Standardization·Ian McGowan
Feb 26, 2014·Contraception·Lisa L Bayer, Jeffrey T Jensen
Jul 19, 2016·Virology·Kabamba B AlexandreM Khati
Aug 24, 2018·Expert Opinion on Drug Safety·Anita L Nelson
Jan 13, 2022·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Ignacio Rodríguez-IzquierdoMa Ángeles Muñoz-Fernández

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Vaginosis

Bacterial vaginosis can increase the risk of sexually transmitted infections and in rare cases lead to pelvic inflammatory diseases. Discover the latest research on Bacterial Vaginosis here.